Jan Krhut
Download the ICS Branding Pack
Podium Short Oral Session 28 Practical Urogynaecology 235 Safety and efficacy of the peroneal electric Transcutaneous NeuroModulation (peroneal eTNM®) versus solifenacin in patients with overactive bladder wet and mixed urinary incontinence
Podium Short Oral Session 21 Overactive Bladder 292 Peroneal electric Transcutaneous NeuroModulation (peroneal eTNM®) is safe and effective in the treatment of the refractory overactive bladder in home-based settings
Open Discussion Session 8 ePoster 2 107 Cardiovascular safety of mirabegron in patients treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity
Podium Short Oral Session 34 Basic Science 3 574 Efficacy and safety of Mirabegron in the treatment of neurogenic detrusor overactivity – prospective, randomized, double-blind, placebo controlled study
Open Discussion Session 7 Open Discussion ePosters 111 Evaluation of treatment efficacy of mirabegron for overactive bladder in patients previously failing anticholinergic therapy
Open Discussion Session 25 Open Discussion ePoster 353 Treatment of stress urinary incontinence using polyacrylamid hydrogel in female patients with and without previous pelvic radiotherapy – 1 year follow-up
Podium Session 28 Neurourology 407 Brain activity associated with urinary bladder filling in patients with a complete spinal cord injury (SCI)- a fMRI study
Non Discussion Poster Session 31 537 Evaluation of the brain activity during pelvic floor contraction using functional magnetic resonance imaging (fMRI)
ICS Member
Prof Jan Krhut declared on the Monday 22nd August 2016 that they had the following existing or known future financial relationships or affiliations:
Scientific Committee Member